291 related articles for article (PubMed ID: 17472676)
41. Ivermectin in human onchocerciasis: a clinical-pathological study of skin lesions before and three days after treatment.
Vuong PN; Traoré S; Wanji S; Diarrassouba S; Balaton A; Bain O
Ann Parasitol Hum Comp; 1992; 67(6):194-6. PubMed ID: 1301733
[TBL] [Abstract][Full Text] [Related]
42. Onchocerciasis prevalence, human migration and risks for onchocerciasis elimination in the Upper Mouhoun, Nakambé and Nazinon river basins in Burkina Faso.
Nikièma AS; Koala L; Post RJ; Paré AB; Kafando CM; Drabo F; Belem AMG; Dabiré RK; Traoré S
Acta Trop; 2018 Sep; 185():176-182. PubMed ID: 29782820
[TBL] [Abstract][Full Text] [Related]
43. A preliminary trial of nifurtimox in the treatment of onchocerciasis.
Fuglsang H; Anderson J
Tropenmed Parasitol; 1978 Sep; 29(3):335-8. PubMed ID: 726047
[TBL] [Abstract][Full Text] [Related]
44. Subcutaneous nodules as a manifestation of onchocerciasis. A rare condition in the United States.
Palomar JM; Bray DM; Grannis FW; Beaver PC
Arch Surg; 1976 Aug; 111(8):909-11. PubMed ID: 942304
[TBL] [Abstract][Full Text] [Related]
45. Pre-control relationship of onchocercal skin disease with onchocercal infection in Guinea Savanna, Northern Nigeria.
Murdoch ME; Murdoch IE; Evans J; Yahaya H; Njepuome N; Cousens S; Jones BR; Abiose A
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005489. PubMed ID: 28355223
[TBL] [Abstract][Full Text] [Related]
46. [Treatment of onchocerciasis with low, increasing doses of suramin in hyperendemic communities of Western Africa: 2. Clinical parasitologic and ophthalmologic results in a zone where transmission is controlled].
Rougemont A; Hien M; Thylefors B; Prost A; Rolland A
Bull World Health Organ; 1984; 62(2):261-9. PubMed ID: 6610495
[No Abstract] [Full Text] [Related]
47. Single dose therapy with ivermectin for onchocerciasis.
Greene BM; White AT; Newland HS; Keyvan-Larijani E; Dukuly ZD; Gallin MY; Aziz MA; Williams PN; Taylor HR
Trans Assoc Am Physicians; 1987; 100():131-8. PubMed ID: 3455063
[No Abstract] [Full Text] [Related]
48. Short report: impact of ivermectin community-level treatments on elimination of adult Onchocerca volvulus when individuals receive multiple treatments per year.
Cupp EW; Cupp MS
Am J Trop Med Hyg; 2005 Dec; 73(6):1159-61. PubMed ID: 16354830
[TBL] [Abstract][Full Text] [Related]
49. Clinical pharmacokinetics of suramin in patients with onchocerciasis.
Chijioke CP; Umeh RE; Mbah AU; Nwonu P; Fleckenstein LL; Okonkwo PO
Eur J Clin Pharmacol; 1998 May; 54(3):249-51. PubMed ID: 9681668
[TBL] [Abstract][Full Text] [Related]
50. Electron microscopical studies on onchocerciasis. II. Skin and microfilariae after treatment with metrifonate.
Burchard GD; Albiez EJ; Bierther M
Tropenmed Parasitol; 1979 Mar; 30(1):97-102. PubMed ID: 375516
[TBL] [Abstract][Full Text] [Related]
51. Situation of onchocerciasis transmission in 2020 in the Cascades region of Burkina Faso.
Guiguemde KT; Sawadogo PM; Zida A; Kima A; Bougma RW; Serme M; Sangaré I; Bougouma C; Bamba S
Parasitol Int; 2024 Feb; 98():102822. PubMed ID: 37940035
[TBL] [Abstract][Full Text] [Related]
52. Ivermectin imposes selection pressure on P-glycoprotein from Onchocerca volvulus: linkage disequilibrium and genotype diversity.
Ardelli BF; Guerriero SB; Prichard RK
Parasitology; 2006 Mar; 132(Pt 3):375-86. PubMed ID: 16280093
[TBL] [Abstract][Full Text] [Related]
53. Ivermectin improves the skin condition and self-esteem of females with onchocerciasis: a report of two cases.
Amazigo UV; Nnoruka E; Maduka C; Bump J; Benton B; Sékétéli A
Ann Trop Med Parasitol; 2004 Jul; 98(5):533-7. PubMed ID: 15257804
[No Abstract] [Full Text] [Related]
54. Pruritus and eosinophilia in a 14-year-old girl from Liberia.
Albert MR; Klion A; Turner ML
J Am Acad Dermatol; 2001 Sep; 45(3):435-7. PubMed ID: 11511842
[No Abstract] [Full Text] [Related]
55. Ivermectin therapy: a 5-year follow-up.
Pacqué M; Greene BM; Muñoz B; Taylor HR
J Infect Dis; 1991 Nov; 164(5):1035-6. PubMed ID: 1940463
[No Abstract] [Full Text] [Related]
56. Onchocerciasis and dracunculosis.
Elgart ML
Dermatol Clin; 1989 Apr; 7(2):323-30. PubMed ID: 2527659
[TBL] [Abstract][Full Text] [Related]
57. [Onchocerciasis].
Takeuchi T
Ryoikibetsu Shokogun Shirizu; 1999; (24 Pt 2):455-7. PubMed ID: 10201255
[No Abstract] [Full Text] [Related]
58. African Programme for Onchocerciasis Control (APOC): sociological study in three foci of central Africa before the implementation of treatments with ivermectin (Mectizan).
Dimomfu BL; Lubeji DK; Noma M; Sékétéli A; Boussinesq M;
Trans R Soc Trop Med Hyg; 2007 Jul; 101(7):674-9. PubMed ID: 17433391
[TBL] [Abstract][Full Text] [Related]
59. Case of creeping disease treated with ivermectin.
Senba Y; Tsuda K; Maruyama H; Kurokawa I; Mizutani H; Taniguchi Y
J Dermatol; 2009 Feb; 36(2):86-9. PubMed ID: 19284451
[TBL] [Abstract][Full Text] [Related]
60. Onchocerciasis in Ecuador. III. Clinical manifestations of the disease in the province of Esmeraldas.
Guderian RH; Molea J; Carrillo R; Proaño R; Swanson WL
Trans R Soc Trop Med Hyg; 1984; 78(1):81-5. PubMed ID: 6710579
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
